PT  - JOURNAL ARTICLE
AU  - Seto, Takashi
AU  - Nosaki, Kaname
AU  - Shimokawa, Mototsugu
AU  - Toyozawa, Ryo
AU  - Sugawara, Shunichi
AU  - Hayashi, Hidetoshi
AU  - Murakami, Haruyasu
AU  - Kato, Terufumi
AU  - Niho, Seiji
AU  - Saka, Hideo
AU  - Oki, Masahide
AU  - Yoshioka, Hiroshige
AU  - Okamoto, Isamu
AU  - Daga, Haruko
AU  - Azuma, Koichi
AU  - Tanaka, Hiroshi
AU  - Nishino, Kazumi
AU  - Tohnai, Rie
AU  - Yamamoto, Nobuyuki
AU  - Nakagawa, Kazuhiko
TI  - Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)
AID  - 10.1136/jitc-2021-004025
DP  - 2022 Feb 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e004025
VI  - 10
IP  - 2
4099  - http://jitc.bmj.com/content/10/2/e004025.short
4100  - http://jitc.bmj.com/content/10/2/e004025.full
SO  - J Immunother Cancer2022 Feb 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.